Stealth Therapeutics Inc. said Wednesday its new port for intravenous treatment has been implanted in a patient for the first time. Read full Journal Sentinel story here.
- Military vets, students may register at discount to attend June 5-6 Entrepreneurs’ ConferenceMay 21, 2018
- WARF: The Wisconsin Idea and Regional Economies: Apples Falling from Many TreesMay 21, 2018
- WisBusiness: ReNeuroGen focuses on improving aftermath for stroke victimsMay 18, 2018
- InsideWis: Even in prosperous times, rural Wisconsin economy faces an uphill climbMay 17, 2018
- Serial software exec, UW grad Erickson to speak June 6 at Entrepreneurs’ ConferenceMay 16, 2018